Cross-Pathy: Can AYUSH Practitioners Legally Prescribe Allopathic Medicine?

Nearly 8,000 homoeopathy practitioners in Maharashtra completed a government-mandated pharmacology bridge course — and, as of early 2026, are still waiting for a Bombay High Court ruling before they can actually use that certification to prescribe allopathic medicines. That single, still-unresolved case captures the state of “cross-pathy” in India better than almost any general statement could: a genuinely contested, actively litigated area of medical law, not the settled question many practitioners assume it to be.

What Cross-Pathy Actually Means

Cross-pathy refers to a practitioner of one recognised system of medicine — most commonly Ayurveda, Homeopathy, Unani, or Siddha (collectively AYUSH) — prescribing or administering treatment from a different system, most often modern allopathic medicine. The reverse (allopathic doctors prescribing AYUSH remedies without training in that system) raises the identical legal issue, though the AYUSH-to-allopathy direction is by far the more commonly litigated and debated version, largely because of the rural healthcare access gap it’s often proposed to solve.

The Foundational Ruling: Mukhtiar Chand (1998)

The Supreme Court’s judgment in Dr. Mukhtiar Chand & Others v. State of Punjab & Others remains the governing precedent on this question. The Court’s central holding was that Indian law does not impose a blanket, universal permission or a blanket, universal ban on cross-system practice — instead, whether a specific AYUSH practitioner may prescribe allopathic medicine depends on the specific state’s own legislation and government orders. Practitioners of Indian medicine holding integrated-course degrees can prescribe allopathic medicines only in states where a general or special government order specifically authorises it, or where the relevant state medical practitioners’ act recognises their particular qualification as sufficient for allopathic registration.

Why This Creates a Genuine Patchwork, Not a National Answer

Because Mukhtiar Chand ties permission to state-specific authorisation rather than establishing a uniform national rule, the practical legal position for an AYUSH practitioner varies significantly depending on where they are registered and practising — a BAMS graduate legally permitted to prescribe certain allopathic medicines in one state may have no such authorisation in another, even holding the identical qualification. This is precisely the kind of state-by-state variation that makes generic online answers ($ Can BAMS doctors prescribe allopathy?”) unreliable without checking the specific state’s current legal position.

The Separate Negligence Standard: Poonam Verma v. Ashwin Patel (1996)

A second, equally important Supreme Court ruling addresses what happens when cross-pathy goes wrong clinically. In Poonam Verma v. Ashwin Patel, the Court held that a doctor practising outside their own trained and registered system of medicine — prescribing medicine from a system they were never trained in — commits medical negligence, reasoning that a practitioner without training in a particular system cannot be fully informed enough to prescribe safely within it, creating real risk of patient harm. This case establishes the liability consequence that sits alongside the registration question from Mukhtiar Chand: even where a state permits some form of cross-practice, a practitioner acting genuinely outside their competence and training remains exposed to a negligence finding.

State-Level Bridge Courses: The Practical Middle Ground

Several states have tried to formalise a limited, training-based pathway rather than leaving the question purely to blanket permission or prohibition. Maharashtra and Tamil Nadu, among others, have introduced provisions under their respective medical practitioners’ acts for “bridge courses” — additional, defined training (commonly in pharmacology) that qualifies certain AYUSH practitioners to prescribe a limited, specifically defined set of allopathic medicines, rather than unrestricted allopathic prescribing rights.

The Maharashtra Case: Where Things Actually Stand in 2026

Maharashtra’s experience illustrates just how unsettled this remains even where a state has actively tried to formalise a pathway. In December 2024, the Maharashtra Food and Drugs Administration issued a directive allowing homoeopathic practitioners who completed a specific pharmacology certificate (the CCMP bridge course) to prescribe certain allopathic medicines. As of March 2026, however, the Maharashtra government confirmed it is still awaiting a final Bombay High Court order on this exact issue — despite nearly 8,000 homoeopathy practitioners having already completed the mandatory bridge course, their certification and the authority to actually use it remain pending final judicial resolution. This is a clear, current illustration that even a state government’s own directive on cross-pathy can remain legally unsettled for a meaningful period, and practitioners relying on such a directive should track its actual litigation status, not just its initial announcement.

The National Bridge Course That Was Proposed and Dropped

At the national level, a broader Bridge Course proposal — under discussion in connection with the National Medical Commission Bill process — sought to create a roughly nine-month standardised training pathway allowing AYUSH practitioners to prescribe allopathic medicines after additional certification. This proposal faced significant opposition, including specific objections that it inappropriately positioned AYUSH doctors as subordinate to allopathic doctors, and it was ultimately dropped rather than enacted. The absence of this national framework is a key reason the current legal landscape remains fragmented at the state level rather than governed by one clear national standard.

The Regulatory Bodies Involved

AYUSH practitioners are governed by their own respective statutory councils — historically the Central Council of Indian Medicine (CCIM) for Ayurveda, Unani, and Siddha, and the Central Council of Homeopathy (CCH) — now largely reorganised under the National Commission for Indian System of Medicine (NCISM) and the National Commission for Homeopathy (NCH). These bodies register practitioners specifically for their own system; holding a valid registration under CCIM/NCISM or CCH/NCH does not, by itself, confer any automatic right to practise modern allopathic medicine — that separate authorisation, where it exists at all, comes only from the specific state-level legal provisions discussed above.

Where the 2022 Supreme Court “No Coercive Action” Order Fits In

In 2022, in a case involving Integrated Systems of Medicine (ISM) practitioners, the Supreme Court granted interim relief directing no coercive action against certain ISM practitioners for practising modern medicine, pending fuller resolution of the underlying dispute. This kind of interim order is a useful illustration of how actively contested and procedurally unresolved cross-pathy remains at the highest judicial level — an interim protection against enforcement action is meaningfully different from a final ruling establishing a clear, permanent legal right, and practitioners should not treat interim relief in one case as a general, nationwide authorisation.

What This Means in Practice

Situation	General Position
AYUSH practitioner in a state with no specific authorising order or bridge course	Prescribing allopathic medicine carries real legal and negligence risk under Mukhtiar Chand and Poonam Verma
AYUSH practitioner who has completed a state-recognised bridge course, in a state where it is legally finalised	Limited, defined prescribing may be permitted — but confirm the course’s actual legal status is finalised, not merely announced
Allopathic doctor employing an AYUSH doctor as an assistant	The employing allopathic doctor bears ultimate responsibility for the AYUSH doctor’s conduct under the 2002 Code’s provisions on running a facility with assistants
Allopathic doctor prescribing AYUSH remedies without training in that system	Raises the same negligence exposure under the Poonam Verma principle, applied in reverse

Frequently Asked Questions

Is cross-pathy legal anywhere in India?

It depends entirely on the specific state and the practitioner’s specific qualification — the Supreme Court’s Mukhtiar Chand ruling ties permission to state-specific government orders or legislation rather than establishing a uniform national rule, so the answer genuinely varies by location.

Can a BAMS doctor legally prescribe allopathic medicines?

Only where the specific state in which they are registered and practising has issued a specific authorising order, or where a state-recognised bridge course applies and is legally finalised — this is not a uniform national right.

What happens if a cross-pathy prescription causes patient harm?

Under the Poonam Verma precedent, a practitioner prescribing outside the system they were trained and registered in can be found negligent, since they are considered not fully informed enough to prescribe safely within an unfamiliar system.

Has Maharashtra’s homoeopathy bridge course been finalised?

As of March 2026, no — nearly 8,000 practitioners had completed the training, but the matter remains pending before the Bombay High Court, so the authorisation to actually use the certification was not yet finalised at that time.

Is there a national law that settles cross-pathy across all of India?

No. A proposed national Bridge Course under the National Medical Commission Bill process was dropped after significant opposition, leaving the current legal landscape fragmented at the state level.

Researched Sources

1. ClearIAS — What is Crosspathy?
2. Drishti IAS — Crosspathy
3. Careers360 — Maharashtra Awaits HC Verdict on CCMP Bridge Course for BHMS Doctors to Prescribe Allopathic Medicines
4. Dr. Ganesh Visavale — Medical Systems Recognized by the NMC: Allopathy, AYUSH, the Cross-Pathy Debate & Licensing

Disclaimer

This article is for general informational and educational purposes and reflects the legal status of cross-pathy as understood at the time of writing; this is an actively litigated and evolving area that varies significantly by state. It is not legal advice; practitioners should consult a qualified healthcare lawyer and confirm their specific state’s current legal position before engaging in any cross-system prescribing.